(EMAILWIRE.COM, June 12, 2021 ) The increasing volume of diagnostic tests performed in anatomic pathology laboratories, rising number of legal cases around cancer misdiagnosis, benefits of automated labeling solutions, increasing consolidation among anatomic pathology laboratories, and the growing adoption of automated systems to enhance the efficiency of laboratories are the major factors driving the growth of this market. However, the high cost associated with the implementation of track and trace solutions in anatomic pathology laboratories is expected to restrain the growth of this market during the forecast period.

Expected Revenue Surge: The Global Anatomic Pathology Track and Trace Solutions Market is projected to reach USD 695.7 million, at a CAGR of 10.4%

Objectives of the Study;

- To define, describe, and forecast the track and trace solutions market on the basis of product, technology, application, end user, and region

- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

- To forecast the size of the anatomic pathology track and trace solutions market with respect to North America, Europe, Asia Pacific, and the Rest of the World

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=124099392

Market Segmentation in Detailed:

On the basis of product,

Broadly segmented into software, hardware, and consumables. In 2018, the software segment is expected to account for the largest share of this market. This can majorly be attributed to the growing need to automate the sample labeling process for reducing manual errors, increasing focus on improving the efficiency of anatomic laboratories, growing adoption of cloud-based LIMS, and the increasing workload in anatomic pathology laboratories.

Basis on Technology,

The anatomic pathology track and trace solutions market is segmented into barcode and RFID. In 2018, the barcode segment is expected to account for a larger share of the market majorly due to the higher adoption of barcode systems among end users owing to their lower cost (as compared to RFID).

Based on application,

Segmented into slide tracking, tissue cassettes and blocks tracking, and specimen tracking. The slide tracking segment is estimated to register the highest CAGR during the forecast period primarily due to the implementation of tracking systems for reducing specimen identification errors and increasing workflow efficiency in anatomic pathology laboratories.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124099392

Geographically; North America is expected to account for the largest share of the anatomic pathology track and trace solutions market in 2018, followed by Europe. The increasing volume of diagnostic tests performed in anatomic pathology laboratories, easy accessibility to advanced technologies, growing demand for advanced cancer diagnostic testing and screening, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the strong presence of leading market players in the region are the major factors responsible for the large share of North America in the anatomic pathology market.

The key players operating in the global anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies Corporation (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US)